Pulmatrix Competitors and Similar CompaniesClear all
Pulmatrix's competitors and similar companies include Ipsen, Vertex Pharmaceuticals, Livzon Pharmaceutical Group and CSL Behring.
 Pulmatrix Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |||
Founding Date | Founding Date 2003 | Founding Date 1929 | Founding Date 1989 | Founding Date 1985 | Founding Date 1904 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Lexington, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 228% decrease | Employees 5,358 | Employees 5,40013% increase | Employees 9,067 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 8 m | Valuation ($) 10.2 b | Valuation ($) 121.4 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $12b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $1.7b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $10.4b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($5.2m) (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 47.7m | Total funding raised N/A | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company